Staging Lung Cancer : Regional Lymph Node Classification - 04/04/18

Doi : 10.1016/j.rcl.2018.01.008

Ahmed H. El-Sherief, MD ^a,^b,^⁎ , Charles T. Lau, MD, MBA ^c, Brett W. Carter, MD ^d, Carol C. Wu, MD ^d
^a Section of Thoracic Imaging, Department of Diagnostic Radiology, Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Building 500, Los Angeles, CA 90073, USA
^b David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
^c Section of Cardiothoracic Imaging, Radiology Service, Veterans Affairs Palo Alto Healthcare System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
^d Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1478, Houston, TX 77030, USA

^∗Corresponding author. Section of Thoracic Imaging, Department of Diagnostic Radiology, Greater Los Angeles Veterans Administration Healthcare System, 11301 Wilshire Boulevard, Building 500, Los Angeles, CA 90073.Section of Thoracic ImagingDepartment of Diagnostic RadiologyGreater Los Angeles Veterans Administration Healthcare System11301 Wilshire BoulevardBuilding 500Los AngelesCA90073

Résumé

This article reviews regional lymph node assessment in lung cancer. In the absence of a distant metastasis, the absence or location of lung cancer spread to a regional mediastinal lymph node affects treatment options and prognosis. Regional lymph node maps have been created to standardize assessment of the N descriptor. The International Association for the Study of Lung Cancer lymph node map is used for the standardization of N descriptor assessment. CT, PET/CT with fluorodeoxyglucose, endobronchial ultrasound–guided and/or esophageal ultrasound–guided biopsy, and mediastinoscopy are common modalities used to determine the N descriptor.

Le texte complet de cet article est disponible en PDF.

Keywords : Lung cancer, Staging, Lymph node, Lymph node map, International association for the study of lung cancer (IASLC)

Plan

Key points

Introduction

International Association for the Study of Lung Cancer lymph node map definitions sets

Regional lymph node (N) classification

Mediastinal lymph node staging

Modalities Used in Mediastinal Lymph Node Staging

Algorithms for Mediastinal Lymph Node Staging

Limitations and future considerations

Summary

Export

Vol 56 - N° 3

P. 399-409 - mai 2018 Retour au numéro

Article précédent

Tumor Staging of Lung Cancer : Essential Concepts for the Radiologist
Constantine A. Raptis, Caroline L. Robb, Sanjeev Bhalla

| Article suivant

Staging Lung Cancer : Metastasis
Girish S. Shroff, Chitra Viswanathan, Brett W. Carter, Marcelo F. Benveniste, Mylene T. Truong, Bradley S. Sabloff

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Staging Lung Cancer : Regional Lymph Node Classification - 04/04/18

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL